• Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4

  2026-08-05

  Morin’s unique dual role as a mitochondrial modulator and fluorescent aluminum ion probe is unlocking new frontiers in diabetes, neurodegenerative, and biochemical assay research. This guide presents optimized workflows, cross-domain applications, and troubleshooting strategies to maximize reproducibility and mechanistic insight.

• PDHA1 Succinylation Drives Immune Escape in Cholangiocarcino

  2026-08-05

  This study reveals that succinylation of PDHA1 at lysine 83 in cholangiocarcinoma leads to metabolic reprogramming, resulting in alpha-ketoglutaric acid accumulation and suppression of macrophage antigen presentation via OXGR1-MAPK signaling. Targeting PDHA1 succinylation enhances sensitivity to gemcitabine and cisplatin, offering a promising route to overcome chemotherapy resistance.

• Thiazovivin: ROCK Inhibitor for Enhanced Stem Cell Survival

  2026-08-04

  Thiazovivin addresses critical bottlenecks in stem cell research, notably by improving the survival of human embryonic stem cells after dissociation and enhancing the efficiency of induced pluripotent stem cell (iPSC) generation. It should be used strictly for scientific research workflows involving cell reprogramming and survival, and is not suitable for diagnostic or therapeutic applications.

• SGC-CBP30: Applied Epigenetics with a CREBBP/EP300 Bromodoma

  2026-08-04

  SGC-CBP30 empowers researchers to dissect transcriptional coactivator functions and super-enhancer hijacking in cancer biology with precision. Its robust selectivity and solubility enable reproducible, high-sensitivity assays in epigenetics and translational oncology.

• CHIR-99021 (CT99021): Precision GSK-3 Inhibition in Advanced

  2026-08-03

  Explore the mechanistic depth and practical workflow advantages of CHIR-99021 (CT99021), a potent GSK-3 inhibitor, in maintaining pluripotency and driving lineage differentiation. This article uniquely bridges molecular insights with assay design for stem cell and regenerative research.

• DMH-1 for ALK2 Inhibition: Precision in Pancreatic and NSCLC

  2026-08-03

  Explore how DMH1, a selective ALK2 inhibitor, advances organoid and non-small cell lung cancer research. This article uniquely bridges high-efficiency organoid generation with tumor biology, revealing untapped assay optimization strategies.

• PPM-18: Precision iNOS Inhibition and Translational Promise

  2026-08-02

  Explore how PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) advances NF-κB/iNOS-targeted inflammation and sepsis research. This article blends mechanistic insight, experimental guidance, and strategic foresight, drawing on recent cardiovascular findings to contextualize translational opportunities.

• AZD8055: Technical Guidance for mTOR Pathway Inhibition

  2026-08-01

  AZD8055 is a potent, selective mTOR inhibitor designed for preclinical research targeting the mTOR pathway in cancer and metabolic biology. It is not suitable for protocols demanding clinical efficacy endpoints or water solubility. This article provides actionable protocol parameters and workflow tips for reliable use.

• Formononetin Prevents CIPN Without Reducing Chemotherapy Eff

  2026-07-31

  This study identifies formononetin as a neuroprotective agent that mitigates oxaliplatin-induced peripheral neurotoxicity via the Nrf2/HO-1 antioxidant pathway, crucially without diminishing the anticancer potency of chemotherapy. These findings provide a foundation for developing strategies to prevent chemotherapy-induced neuropathy while preserving oncological outcomes.

• Refining Calcium Channel Pharmacology: Insights from v-Agato

  2026-07-31

  Sidach and Mintz's 2000 study redefines the selectivity of the spider toxin v-agatoxin-IVA, showing that at higher concentrations, it blocks not only P-type but also N-type calcium channels in mammalian neurons. This finding challenges longstanding classification schemes and has significant implications for neurophysiological research relying on toxin-based channel antagonists.

• Thiazovivin for Stem Cell Survival and iPSC Generation Workf

  2026-07-30

  Thiazovivin is a small-molecule ROCK inhibitor designed to enhance the efficiency of induced pluripotent stem cell (iPSC) generation and improve human embryonic stem cell (hESC) survival after dissociation. It is best suited for stem cell research protocols requiring high cell viability and reprogramming rates, but is not indicated for diagnostic or therapeutic use.

• CHIR-99021: Advancing Stem Cell Pluripotency and Organoid Mo

  2026-07-30

  CHIR-99021 (CT99021) empowers researchers to precisely modulate Wnt/β-catenin signaling and maintain embryonic stem cell pluripotency, enabling new horizons in organoid development and tissue engineering. Recent studies highlight CHIR-99021's unique role in driving multi-lineage limb organoid self-organization, making it indispensable for advanced in vitro modeling.

• SIS3 (Smad3 Inhibitor): Precision Tool for Fibrosis Research

  2026-07-29

  SIS3 delivers high specificity for Smad3 inhibition, enabling researchers to dissect the TGF-β signaling pathway in fibrosis and osteoarthritis models with confidence. Discover stepwise workflows, protocol optimization, and actionable troubleshooting strategies for maximizing experimental reproducibility.

• Praeruptorin A Suppresses NF-κB-Mediated Inflammation in Mac

  2026-07-29

  This study demonstrates that Praeruptorin A, an angular pyranocoumarin compound, robustly inhibits NF-κB pathway activation and pro-inflammatory gene expression in poly (I:C)-stimulated RAW264.7 macrophages. These mechanistic insights position Praeruptorin A as a valuable tool for dissecting antiviral and inflammatory signaling in immune cell models.

• Cyclosporin A: Immunosuppressive Mechanisms and Research Uti

  2026-07-28

  Cyclosporin A is a cyclic undecapeptide with potent immunosuppressive and mitochondrial regulatory actions. It exerts its effects by inhibiting calcineurin via cyclophilin binding, blocking T-cell activation and cytokine expression. Its high membrane permeability underpins both clinical and research applications, including organ transplantation immunosuppression and mitochondrial function assays.

16261 records 1/1085 page Next 12345 下5页 Last page